Risky Stem-Cell Treatments Come Under F.D.A. Scrutiny — Again Warning that unapproved stem-cell treatments put patients at risk, the F.D.A. is notifying clinics and manufacturers that flout its rules. Share: Facebook Twitter Google+ Stumble Digg Email ThisBlogThis!Share to XShare to Facebook Related Posts:BAE systems' new hybrid drones to 'revolutionise' warfareTrilobites: Who’s Eating Jellyfish? Penguins, That’s WhoFear of Volcano Eruption on Bali Drives 145,000 From HomesWhat is Elon Musk’s net worth? How much money does Tesla founder have?Cost of Contact in Sports Is Estimated at Over 600,000 Injuries a YearArming China’s Terracotta Warriors — With Your Phone
